Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check6 days agoChange DetectedAdded Severe myoclonic epilepsy in infancy as a related topic and introduced a Genetic and Rare Diseases Information Center resource in the Resources section.SummaryDifference0.1%

- Check13 days agoChange DetectedRemoved the study's condition label 'Dravet syndrome' and the Genetic and Rare Diseases Information Center resource from the page.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.2 is now displayed; the government funding operating-status notice (and the v3.4.1 revision note) has been removed.SummaryDifference0.3%

- Check63 days agoChange DetectedA new site-wide notice about potential delays due to a lapse in government funding has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.